Colonisation of the nasopharynx with BLIS K12 and inhibition of growth of pathogens in healthy adult volunteers.

Not Applicable

Completed

• Conditions: otitis media; Alternative and Complementary Medicine - Other alternative and complementary medicine; Infection - Studies of infection and infectious agents; Ear - Other ear disorders

• Registration Number: ACTRN12619000779178
• Lead Sponsor: BLIS technologies

Brief Summary

no results yet

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-27
• Study Completion: 2020-02-28
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

All healthy adults volunteers.

Exclusion Criteria

Concurrent or recent (<12 weeks) use of any form of antibiotics, known allergy to BLIS products, active infection of the upper respiratory tract (including paranasal sinuses).

Study & Design

• Study Type: Interventional
• Study Design: Not specified